Saphris Sublingual Tablet 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Saphris: Sublingual tablet (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Saphris 10mg Sublingual Tablet
Drug Image file default-drug-image.png
Saphris 10mg Sublingual Tablet
Drug Image file DrugItem_12236.JPG
Saphris 10mg SL Tab
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: 10 

What is this Medicine?

ASENAPINE (a SEN a peen) is used to treat schizophrenia and bipolar disorder.

CVS Pharmacy Patient Statistics for Saphris: Sublingual tablet(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Saphris 10mg Sublingual Tablet (Black Cherry)

NDC: 000522142
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Schizophrenia, Bipolar Disorder

Sometimes used for but not FDA approved for the following conditions:
Agitation

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Saphris 10mg Sublingual Tablet (Black Cherry)

Reported Side Effects for Saphris 10mg Sublingual Tablet (Black Cherry)

Muscle Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Postural Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
<7.0%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
<0.2%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<11.4%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<0.3%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<3.0%*
Severity: MODERATE
Onset: RAPID
Heartburn Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<2.5%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
<8.7%*
Severity: MODERATE
Onset: DELAYED
High Prolactin Level Incidence:
<2.6%*
Severity: MODERATE
Onset: DELAYED
Extra Saliva Production Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Inflamed Tongue Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
0.1-30.0%*
Severity: MILD
Onset: DELAYED
Photosensitivity Incidence:
0.1-0.9%*
Severity: MILD
Onset: DELAYED
Blurred Vision Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Double Vision Incidence:
0.1-0.9%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
0.1-0.9%*
Severity: SEVERE
Onset: EARLY
Dysarthria Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Bundle-branch Block Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: EARLY
Low Blood Sodium Levels Incidence:
0.1-0.9%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Pseudoparkinsonism Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Menstrual Cramps Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Irritability Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Thoughts Of Suicide Incidence:
1.0-4.0%*
Severity: SEVERE
Onset: DELAYED
Restlessness Incidence:
1.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
High Triglycerides Incidence:
1.9-15.2%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
2.0-14.7%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Tooth Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
3.0-16.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
3.0-14.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
3.0-6.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
3.0-11.0%*
Severity: MILD
Onset: EARLY
Hypoesthesia Incidence:
4.0-7.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
4.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.0-12.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
13.0-53.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Saphris 10mg Sublingual Tablet (Black Cherry)

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Saphris 10mg Sublingual Tablet (Black Cherry)(Asenapine)
Alcohol and CNS Depressants(Asenapine)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Saphris

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.